HeartBeam (NASDAQ: BEAT) will hold a conference call on November 13, 2025, at 4:30 p.m. ET to discuss its third quarter 2025 financial results and provide updates on regulatory progress and commercial-readiness activities. The medical technology company, which is transforming cardiac care through personalized insights, will also discuss upcoming milestones during the call covering the period ended September 30, 2025.
The company's technology represents a significant advancement in cardiac care by creating the first-ever cable-free device capable of collecting ECG signals in three dimensions from non-coplanar directions and synthesizing these signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is located, delivering actionable heart intelligence directly to physicians. The innovation enables healthcare providers to identify cardiac health trends and acute conditions while directing patients to appropriate care outside traditional medical facilities.
HeartBeam's 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, marking a critical regulatory milestone. The company's 12-Lead ECG synthesis software remains under FDA review, representing the next phase of regulatory advancement. With over 20 issued patents related to technology enablement, HeartBeam has established substantial intellectual property protection for its cardiac monitoring innovations.
The upcoming conference call is significant for investors and the healthcare industry as it will provide insights into the company's financial performance and regulatory progress. The technology's potential to redefine cardiac health management by enabling remote monitoring could substantially impact how cardiac conditions are detected and managed worldwide. Portable ECG technology that can generate clinical-grade 12-lead readings outside medical facilities addresses critical gaps in cardiac care accessibility and early detection capabilities.
Additional information about the company is available through its newsroom at https://ibn.fm/BEAT, while the full press release can be accessed at https://ibn.fm/5mXsb. The technology's advancement comes at a time when remote patient monitoring and telehealth services are increasingly important components of healthcare delivery systems globally.
